Eric Dobmeier
2021
In 2021, Eric Dobmeier earned a total compensation of $3.6M as President and Chief Executive Officer at Aduro BioTech, a 42% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $285,938 |
|---|---|
| Option Awards | $1,835,633 |
| Salary | $547,250 |
| Stock Awards | $919,649 |
| Other | $2,500 |
| Total | $3,590,970 |
Dobmeier received $1.8M in option awards, accounting for 51% of the total pay in 2021.
Dobmeier also received $285.9K in non-equity incentive plan, $547.3K in salary, $919.6K in stock awards and $2.5K in other compensation.
Rankings
In 2021, Eric Dobmeier's compensation ranked 3,712th out of 12,415 executives tracked by ExecPay. In other words, Dobmeier earned more than 70.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,712 out of 12,415 | 70th |
Division Manufacturing | 1,506 out of 5,505 | 73rd |
Major group Chemicals And Allied Products | 612 out of 2,375 | 74th |
Industry group Drugs | 543 out of 2,096 | 74th |
Industry Pharmaceutical Preparations | 382 out of 1,546 | 75th |
Source: SEC filing on April 14, 2022.
Dobmeier's colleagues
We found two more compensation records of executives who worked with Eric Dobmeier at Aduro BioTech in 2021.